BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hsieh PS, Hsieh YJ. Impact of liver diseases on the development of type 2 diabetes mellitus. World J Gastroenterol 2011; 17(48): 5240-5245 [PMID: 22219592 DOI: 10.3748/wjg.v17.i48.5240]
URL: https://www.wjgnet.com/1007-9327/full/v17/i48/5240.htm
Number Citing Articles
1
Carmen Andrea Pfortmueller, Christoph Wiemann, Georg-Christian Funk, Alexander Benedikt Leichtle, Georg Martin Fiedler, Aristomenis Konstantinos Exadaktylos, Gregor Lindner. Hypoglycemia is associated with increased mortality in patients with acute decompensated liver cirrhosisJournal of Critical Care 2014; 29(2): 316.e7 doi: 10.1016/j.jcrc.2013.11.002
2
Thaïs Rouquet, Marion S Bonnet, Clément Pierre, Michel Dallaporta, Jean-Denis Troadec, Julien Roux, Bruno Bariohay. The central question of type 2 diabetesPharmaceutical Patent Analyst 2013; 2(3): 399 doi: 10.4155/ppa.13.22
3
Wen-You Zhang, Huan-Huan Zhang, Chen-Huan Yu, Jie Fang, Hua-Zhong Ying. Ethanol extract of Atractylodis macrocephalae Rhizoma ameliorates insulin resistance and gut microbiota in type 2 diabetic db/db miceJournal of Functional Foods 2017; 39: 139 doi: 10.1016/j.jff.2017.10.020
4
C. H. Jung, W. J. Lee, J. Y. Hwang, J. H. Yu, M. S. Shin, M. J. Lee, J. E. Jang, J. Leem, J.-Y. Park, H.-K. Kim. Assessment of the fatty liver index as an indicator of hepatic steatosis for predicting incident diabetes independently of insulin resistance in a Korean populationDiabetic Medicine 2013; 30(4): 428 doi: 10.1111/dme.12104
5
Vladislav Volarevic, Maja Misirkic, Ljubica Vucicevic, Verica Paunovic, Bojana Simovic Markovic, Maja Stojanovic, Marija Milovanovic, Vladimir Jakovljevic, Dragan Micic, Nebojsa Arsenijevic, Vladimir Trajkovic, Miodrag L. Lukic. Metformin aggravates immune-mediated liver injury in miceArchives of Toxicology 2015; 89(3): 437 doi: 10.1007/s00204-014-1263-1
6
Yuanyuan Li, Ying Zhao, Jianping Wu, Ferruccio Bonino. Serum HBV surface antigen positivity is associated with low prevalence of metabolic syndrome: A meta-analysisPLOS ONE 2017; 12(5): e0177713 doi: 10.1371/journal.pone.0177713
7
Marleen M.J. van Greevenbroek, Casper G. Schalkwijk, Coen D.A. Stehouwer. Inflammation - From Molecular and Cellular Mechanisms to the Clinic2017; : 1225 doi: 10.1002/9783527692156.ch47
8
Xin Wang, Jing Ke, Ying-jun Zhu, Bin Cao, Rui-li Yin, Yan Wang, Ling-ling Wei, Li-jie Zhang, Long-yan Yang, Dong Zhao. Dipeptidyl peptidase-4 (DPP4) inhibitor sitagliptin alleviates liver inflammation of diabetic mice by acting as a ROS scavenger and inhibiting the NFκB pathwayCell Death Discovery 2021; 7(1) doi: 10.1038/s41420-021-00625-7
9
Yi-Wen Huang, Ting-Chuan Wang, Shih-Chang Lin, Han-Yu Chang, Ding-Shinn Chen, Jui-Ting Hu, Sien-Sing Yang, Jia-Horng Kao. Increased Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients With Newly Diagnosed Diabetes: A Nationwide Cohort StudyClinical Infectious Diseases 2013; 57(12): 1695 doi: 10.1093/cid/cit603
10
Chia-Chi Wang, Tai-Chung Tseng, Jia-Horng Kao. Hepatitis B virus infection and metabolic syndrome: Fact or fiction?Journal of Gastroenterology and Hepatology 2015; 30(1): 14 doi: 10.1111/jgh.12700
11
Cong Zhang, Caiyun Sun, Bin Wang, Peipei Yan, Amin Wu, Guokun Yang, Wensheng Li. Orexin-A stimulates the expression of GLUT4 in a glucose dependent manner in the liver of orange-spotted grouper ( Epinephelus coioides )Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology 2016; 199: 95 doi: 10.1016/j.cbpa.2016.05.027
12
L.-N. Xu, L.-H. Yin, Y. Jin, Y. Qi, X. Han, Y.-W. Xu, K.-X. Liu, Y.-Y. Zhao, J.-Y. Peng. Effect and possible mechanisms of dioscin on ameliorating metabolic glycolipid metabolic disorder in type-2-diabetesPhytomedicine 2020; 67: 153139 doi: 10.1016/j.phymed.2019.153139
13
Ping-Hsin Hsieh, Jing-Yang Huang, Oswald Ndi Nfor, Chia-Chi Lung, Chien-Chang Ho, Yung-Po Liaw. Association of type 2 diabetes with liver cirrhosis: a nationwide cohort studyOncotarget 2017; 8(46): 81321 doi: 10.18632/oncotarget.18466
14
Yange Wei, Haixia Yang, Chenhui Zhu, Jianjun Deng, Daidi Fan. Hypoglycemic Effect of Ginsenoside Rg5 Mediated Partly by Modulating Gut Microbiota Dysbiosis in Diabetic db/db MiceJournal of Agricultural and Food Chemistry 2020; 68(18): 5107 doi: 10.1021/acs.jafc.0c00605
15
André J. Scheen. Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes MellitusClinical Pharmacokinetics 2014; 53(9): 773 doi: 10.1007/s40262-014-0157-y
16
F. Rajas, P. Labrune, G. Mithieux. Glycogen storage disease type 1 and diabetes: Learning by comparing and contrasting the two disordersDiabetes & Metabolism 2013; 39(5): 377 doi: 10.1016/j.diabet.2013.03.002
17
Fei Lan, Hirofumi Misu, Keita Chikamoto, Hiroaki Takayama, Akihiro Kikuchi, Kensuke Mohri, Noboru Takata, Hiroto Hayashi, Naoto Matsuzawa-Nagata, Yumie Takeshita, Hiroyo Noda, Yukako Matsumoto, Tsuguhito Ota, Toru Nagano, Masatoshi Nakagen, Ken-ichi Miyamoto, Kanako Takatsuki, Toru Seo, Kaito Iwayama, Kunpei Tokuyama, Seiichi Matsugo, Hong Tang, Yoshiro Saito, Satoshi Yamagoe, Shuichi Kaneko, Toshinari Takamura. LECT2 Functions as a Hepatokine That Links Obesity to Skeletal Muscle Insulin ResistanceDiabetes 2014; 63(5): 1649 doi: 10.2337/db13-0728
18
Michael Leutner, Christian Göbl, Oliver Schlager, Silvia Charwat-Resl, Alice Wielandner, Eleonora Howorka, Marlies Prünner, Latife Bozkurt, Katharina Maruszczak, Hacer Geyik, Helmut Prosch, Giovanni Pacini, Alexandra Kautzky-Willer. The Fatty Liver Index (FLI) Relates to Diabetes-Specific Parameters and an Adverse Lipid Profile in a Cohort of Nondiabetic, Dyslipidemic PatientsJournal of the American College of Nutrition 2017; 36(4): 287 doi: 10.1080/07315724.2016.1262802
19
John Marcinak, Majid Vakilynejad, Akifumi Kogame, Yoshihiko Tagawa. Evaluation of the Pharmacokinetics and Safety of a Single Oral Dose of Fasiglifam in Subjects with Mild or Moderate Hepatic ImpairmentDrugs in R&D 2018; 18(2): 109 doi: 10.1007/s40268-018-0229-9
20
Shintaro Yagi, Toshimi Kaido, Taku Iida, Atsushi Yoshizawa, Hideaki Okajima, Shinji Uemoto. New-onset diabetes mellitus after living-donor liver transplantation: association with graft synthetic functionSurgery Today 2017; 47(6): 733 doi: 10.1007/s00595-016-1444-z
21
Alper Sonmez, Teoman Dogru, Cemal Nuri Ercin, Halil Genc, Gurkan Celebi, Hasan Gurel, Serkan Tapan, Ali Fuat Cicek, Cem Barcin, Cem Haymana, Ali Kirik, Manfredi Rizzo. Betatrophin Levels Are Related to the Early Histological Findings in Nonalcoholic Fatty Liver DiseaseMetabolites 2021; 11(7): 425 doi: 10.3390/metabo11070425
22
Xiu-Ping Bai, Yong-Mei Fan, Lei Zhang, Guo-Hua Yang, Xing Li. Influence of Liver Cirrhosis on Blood Glucose, Insulin Sensitivity and Islet Function in MiceThe American Journal of the Medical Sciences 2021; 362(4): 403 doi: 10.1016/j.amjms.2021.07.005
23
Pankaj Puri, Narendra Kotwal. An Approach to the Management of Diabetes Mellitus in Cirrhosis: A Primer for the HepatologistJournal of Clinical and Experimental Hepatology 2022; 12(2): 560 doi: 10.1016/j.jceh.2021.09.010
24
Lindokuhle Patience Mabuza, Mlindeli Wilkinson Gamede, Sanam Maikoo, Irvin Noel Booysen, Phikelelani Siphosethu Nguban, Andile Khathi. Hepatoprotective Effects of a Ruthenium(II) Schiff Base Complex in Rats with Diet-Induced PrediabetesCurrent Therapeutic Research 2019; 91: 66 doi: 10.1016/j.curtheres.2019.100570
25
Zobair Younossi, Katrin Kochems, Marc de Ridder, Desmond Curran, Eveline M. Bunge, Laurence de Moerlooze. Should adults with diabetes mellitus be vaccinated against hepatitis B virus? A systematic review of diabetes mellitus and the progression of hepatitis B diseaseHuman Vaccines & Immunotherapeutics 2017; 13(11): 2695 doi: 10.1080/21645515.2017.1353850
26
Javier Ampuero, Manuel Romero-Gómez. Influencia de la enfermedad por hígado graso no alcohólico en la enfermedad cardiovascularGastroenterología y Hepatología 2012; 35(8): 585 doi: 10.1016/j.gastrohep.2012.02.005
27
Roaid Khan, Graham R. Foster, Tahseen A. Chowdhury. Managing Diabetes in Patients with Chronic Liver DiseasePostgraduate Medicine 2012; 124(4): 130 doi: 10.3810/pgm.2012.07.2574
28
Joo-Won Park, Woo-Jae Park, Yael Kuperman, Sigalit Boura-Halfon, Yael Pewzner-Jung, Anthony H. Futerman. Ablation of very long acyl chain sphingolipids causes hepatic insulin resistance in mice due to altered detergent-resistant membranesHepatology 2013; 57(2): 525 doi: 10.1002/hep.26015
29
Carlo B. Giorda, Elisa Nada, Barbara Tartaglino. Pharmacokinetics, safety, and efficacy of DPP-4 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus and renal or hepatic impairment. A systematic review of the literatureEndocrine 2014; 46(3): 406 doi: 10.1007/s12020-014-0179-0
30
André J Scheen. Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver diseaseExpert Opinion on Drug Metabolism & Toxicology 2014; 10(6): 839 doi: 10.1517/17425255.2014.902444
31
Tae Woo Jung, Yoon Hee Chung, Hyoung-Chun Kim, A.M. Abd El-Aty, Ji Hoon Jeong. Hyperlipidemia-induced hepassocin in the liver contributes to insulin resistance in skeletal muscleMolecular and Cellular Endocrinology 2018; 470: 26 doi: 10.1016/j.mce.2017.10.014
32
Mina Bakhshaeshi, Arash Khaki, Fatemeh Fathiazad, Amir Afshin Khaki, Elham Ghadamkheir. Anti–oxidative role of quercetin derived from Allium cepa on aldehyde oxidase (OX–LDL) and hepatocytes apoptosis in streptozotocin–induced diabetic ratAsian Pacific Journal of Tropical Biomedicine 2012; 2(7): 528 doi: 10.1016/S2221-1691(12)60090-2
33
Hirofumi Misu. Pathophysiological significance of hepatokine overproduction in type 2 diabetesDiabetology International 2018; 9(4): 224 doi: 10.1007/s13340-018-0368-9
34
Muhammad Sadik Memon, Zain Islam Arain, Farukh Naz, Madiha Zaki, Suresh Kumar, Asif Ali Burney. Prevalence of Type 2 Diabetes Mellitus in Hepatitis C Virus Infected Population: A Southeast Asian StudyJournal of Diabetes Research 2013; 2013: 1 doi: 10.1155/2013/539361
35
Yasmin Saad, Abobakr Awad, Wafaa Alakel, Wahid Doss, Tahany Awad, Mahasen Mabrouk. Data mining of routine laboratory tests can predict liver disease progression in Egyptian diabetic patients with hepatitis C virus (G4) infectionEuropean Journal of Gastroenterology & Hepatology 2018; 30(2): 201 doi: 10.1097/MEG.0000000000001008
36
Simona Alexandra Iacob, Diana Gabriela Iacob. Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis BreakdownFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.814209
37
Yi Shen, Sheng Zhang, Xulin Wang, Yuanyuan Wang, Jian Zhang, Gang Qin, Wenchao Li, Kun Ding, Lei Zhang, Feng Liang. Comparison of type 2 diabetes mellitus incidence in different phases of hepatitis B virus infection: A meta-analysisLiver International 2017; 37(10): 1451 doi: 10.1111/liv.13275
38
Yi-Wen Huang, Sien-Sing Yang, Szu-Chieh Fu, Ting-Chuan Wang, Cheng-Kai Hsu, Ding-Shinn Chen, Jui-Ting Hu, Jia-Horng Kao. Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new-onset diabetes: A nationwide cohort studyHepatology 2014; 60(3): 807 doi: 10.1002/hep.27212
39
Jialin Zheng, Heng Li, Xiaojuan Zhang, Min Jiang, Chunqin Luo, Zhenming Lu, Zhenghong Xu, Jinsong Shi. Prebiotic Mannan-Oligosaccharides Augment the Hypoglycemic Effects of Metformin in Correlation with Modulating Gut MicrobiotaJournal of Agricultural and Food Chemistry 2018; 66(23): 5821 doi: 10.1021/acs.jafc.8b00829